Using machine learning to predict radiation pneumonitis in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy

Using machine learning to predict radiation pneumonitis in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy
复制标题

DOI:
10.1088/0031-9155/61/16/6105
复制
发表时间:
2016-08-21
影响因子:
3.5
通讯作者:
Simone, Charles B., II
Simone, Charles B., II
中科院分区:
工程技术2区
文献类型:
--
作者:
Valdes, Gilmer;Solberg, Timothy D.;Simone, Charles B., II

文献摘要

被引文献

相似文献

开发一种针对患者的“大数据”临床决策工具,用于预测立体定向全身放射治疗(SBRT)后I期非小细胞肺癌(NSCLC)患者的肺炎。在201例连续接受SBRT治疗的I期NSCLC患者中记录了61个特征,其中8例(4.0%)发生了放射性肺炎。使用决策树桩分别为每个特征找到肺炎阈值。评估了三种不同算法(决策树、随机森林、RUSBoost)的性能。绘制学习曲线,对训练误差进行分析,并与测试误差进行比较,以评估获得交叉验证误差小于0.1所需的因素。其中包括增加新特征,增加算法的复杂性,扩大样本量和事件数量。在单因素分析中,选择的最重要特征是肺对一氧化碳的扩散能力(DLCO %)。在多变量分析中,选择的三个最重要的特征是心脏剂量为15cc,气管或支气管剂量为4cc,以及种族。如果将RUSBoost算法与正则化结合使用,则可以获得更高的精度。为了在误差小于10%的范围内预测放射性肺炎,我们估计需要800名患者的样本量。在201例接受SBRT治疗的I期NSCLC患者队列中确定了患者发生放射性肺炎风险的临床相关阈值。这些阈值的一致性可以为放射肿瘤学家提供其可靠性的估计,并可能为治疗计划和患者咨询提供信息。分类的准确性受到研究中患者数量的限制,而不受收集到的特征或算法的复杂性的限制。
To develop a patient-specific 'big data' clinical decision tool to predict pneumonitis in stage I non-small cell lung cancer (NSCLC) patients after stereotactic body radiation therapy (SBRT).61 features were recorded for 201 consecutive patients with stage I NSCLC treated with SBRT, in whom 8 (4.0%) developed radiation pneumonitis. Pneumonitis thresholds were found for each feature individually using decision stumps. The performance of three different algorithms (Decision Trees, Random Forests, RUSBoost) was evaluated. Learning curves were developed and the training error analyzed and compared to the testing error in order to evaluate the factors needed to obtain a cross-validated error smaller than 0.1. These included the addition of new features, increasing the complexity of the algorithm and enlarging the sample size and number of events.In the univariate analysis, the most important feature selected was the diffusion capacity of the lung for carbon monoxide (DLCO adj%). On multivariate analysis, the three most important features selected were the dose to 15 cc of the heart, dose to 4 cc of the trachea or bronchus, and race. Higher accuracy could be achieved if the RUSBoost algorithm was used with regularization. To predict radiation pneumonitis within an error smaller than 10%, we estimate that a sample size of 800 patients is required.Clinically relevant thresholds that put patients at risk of developing radiation pneumonitis were determined in a cohort of 201 stage I NSCLC patients treated with SBRT. The consistency of these thresholds can provide radiation oncologists with an estimate of their reliability and may inform treatment planning and patient counseling. The accuracy of the classification is limited by the number of patients in the study and not by the features gathered or the complexity of the algorithm.